Urologic oncology focuses on the diagnosis and treatment of cancers affecting the urinary system and male reproductive organs, including the prostate, kidneys, bladder and testicles.
Dr. Nitin Singhal provides specialised surgical oncology care for selected urological cancers, with an emphasis on evidence-based treatment, minimally invasive surgery and a patient-specific approach.
Urologic cancers can affect different parts of the urinary and male reproductive systems. These include prostate cancer, kidney cancer, bladder cancer and testicular cancer.
The appropriate treatment depends on the type and stage of cancer, tumour characteristics, location, overall health and individual treatment goals.
A detailed evaluation helps determine whether surgery, robotic surgery, chemotherapy, immunotherapy, radiation therapy, targeted treatment or a combination of approaches may be appropriate.
There is no single surgical approach that is suitable for every patient. Depending on the cancer and clinical circumstances, treatment may involve robotic, laparoscopic or open surgery. The objective is to select the approach that provides the most appropriate balance of cancer control, safety and functional preservation.
Surgical treatment is selected according to the cancer type, stage, tumour characteristics and patient's individual condition.
Robotic radical prostatectomy may be considered for selected patients with localised prostate cancer. The procedure uses minimally invasive access and enhanced visualization to remove the prostate while aiming to preserve important surrounding structures when clinically possible.
Depending on tumour size, location and complexity, kidney cancer surgery may involve robotic partial nephrectomy or robotic radical nephrectomy. Partial nephrectomy aims to remove the tumour while preserving healthy kidney tissue whenever appropriate.
Selected patients with bladder cancer may require procedures ranging from TURBT for appropriate early-stage tumours to radical cystectomy for muscle-invasive disease. Robotic techniques may be considered for selected complex cases.
Testicular cancer treatment commonly involves radical inguinal orchiectomy. If cancer has spread, additional treatment such as retroperitoneal lymph node dissection may be considered depending on the individual case.
Minimally invasive approaches may offer smaller incisions and enhanced visualization for selected procedures. The surgical approach is selected according to the patient's condition rather than technology alone.
Complex urological cancers may require coordinated care involving surgical oncology, medical oncology, radiation oncology, radiology and pathology to develop an appropriate treatment plan.
Robotic radical prostatectomy is a surgical treatment for selected patients with localised prostate cancer. Using a minimally invasive robotic approach, the surgeon removes the prostate and may aim to preserve important surrounding structures when appropriate.
Potential advantages of minimally invasive robotic prostate cancer surgery may include:
A prostate biopsy may be recommended when clinical findings, PSA levels, imaging or other investigations raise concern about prostate cancer. The biopsy helps confirm the diagnosis and provides information needed to determine the appropriate treatment strategy.
Transurethral Resection of Bladder Tumor (TURBT) is commonly used to diagnose and remove selected superficial bladder tumours. Further treatment depends on the pathology, stage and risk category.
For selected patients with muscle-invasive bladder cancer, radical cystectomy involves removal of the bladder. A robotic approach may provide minimally invasive access with enhanced visualization during complex surgery.
Following bladder removal, urinary reconstruction may be required. Depending on the patient's clinical situation, options can include:
Robotic radical nephrectomy involves removal of the affected kidney and may be considered for selected larger or complex kidney tumours when complete kidney removal is clinically appropriate.
Whenever appropriate, robotic partial nephrectomy aims to remove the kidney tumour while preserving healthy kidney tissue. The suitability of this kidney-sparing approach depends on tumour size, location, complexity and kidney function.
The standard surgical treatment for many testicular cancers is radical inguinal orchiectomy, which involves removal of the affected testicle and spermatic cord.
When cancer has spread, additional treatment may be required. Retroperitoneal lymph node dissection (RPLND) may be considered in selected patients depending on the cancer type, stage and treatment plan.
Dr. Nitin Singhal is a surgical oncologist with more than 15 years of experience in cancer surgery and advanced surgical oncology. He received surgical oncology training from the world-renowned Tata Memorial Hospital, Mumbai.
His approach focuses on evidence-based treatment planning and selecting the surgical technique according to the patient's cancer, anatomy and clinical requirements.
If you or a family member has been diagnosed with prostate, kidney, bladder or another urological cancer, consult a surgical oncology specialist to understand the available treatment options and whether robotic or minimally invasive surgery may be appropriate.
Answers to common questions about robotic urologic oncology, prostate cancer, kidney cancer, bladder cancer and other urological cancer treatments.
Urologic oncology is a specialised area of cancer care focused on cancers affecting the urinary system and male reproductive organs. This includes prostate cancer, kidney cancer, bladder cancer and testicular cancer.
Treatment is selected according to the type and stage of cancer, tumour characteristics, overall health and individual treatment goals.
Robotic urologic cancer surgery is a minimally invasive surgical approach in which the surgeon controls specialised robotic instruments. It can provide enhanced visualization, magnification and precise instrument control during selected complex procedures.
Robotic surgery is considered when it is appropriate for the patient's cancer, anatomy and overall clinical condition.
Depending on the cancer type, stage, tumour location and individual clinical factors, robotic surgery may be considered for selected prostate, kidney and bladder cancers.
Not every patient or tumour is suitable for a robotic approach. The recommended technique is determined after detailed evaluation.
For appropriately selected patients, robotic radical prostatectomy provides minimally invasive access with enhanced visualization during surgery.
Potential benefits may include smaller incisions, reduced blood loss, less postoperative discomfort and faster recovery. Preservation of important structures may also be considered where clinically appropriate.
Robotic partial nephrectomy is a kidney-sparing operation used for selected kidney tumours. The aim is to remove the tumour while preserving as much healthy kidney tissue as possible.
Suitability depends on tumour size, location, complexity, kidney function and the patient's overall health.
Bladder cancer treatment depends on the type and stage of disease. TURBT may be used for selected superficial bladder tumours, while muscle-invasive bladder cancer may require radical cystectomy.
In selected patients, a robotic approach may be used for radical cystectomy and can provide minimally invasive access during complex surgery.
No. Robotic surgery is not automatically the right choice for every patient. The approach depends on the cancer type, stage, tumour anatomy, previous treatments, overall health and surgical requirements.
Depending on the individual situation, robotic, laparoscopic or open surgery may be considered. The goal is to select the approach most appropriate for the patient's condition.
Patients may consider the surgeon's training, surgical oncology experience, expertise in the specific cancer being treated, access to appropriate technology and multidisciplinary cancer care.
It is also important to understand whether robotic surgery is genuinely appropriate for the individual cancer rather than selecting an approach based only on the availability of technology.
Robotic kidney cancer surgery uses minimally invasive robotic techniques for selected kidney tumours. Depending on the tumour and clinical situation, surgery may involve robotic partial nephrectomy or robotic radical nephrectomy.
The surgical plan depends on tumour size, location, complexity, kidney function and overall health.
A urologic oncologist may be consulted after a diagnosis of prostate, kidney, bladder or another urological cancer, or when investigations identify a suspicious abnormality requiring specialist assessment.
Specialist evaluation can help patients understand the diagnosis, stage and available treatment options, including whether surgery, robotic surgery or another treatment approach may be appropriate.
Dr. Nitin Singhal has been recognised for his contribution to cancer care and surgical oncology, reflecting his commitment to advanced surgical techniques, clinical excellence and patient-centred care.
Surgical oncology training from Tata Memorial Hospital, Mumbai.
Expertise across complex and multidisciplinary cancer surgery.
Honoured for excellence in healthcare and surgical oncology.
Focus on evidence-based and personalised cancer treatment.
Recognition that reflects a continued commitment to excellence in cancer care.
